Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 09, 2019

SELL
$1.22 - $2.41 $12,200 - $24,100
-10,000 Closed
0 $0
Q3 2018

Oct 11, 2018

SELL
$1.75 - $2.93 $7,000 - $11,720
-4,000 Reduced 28.57%
10,000 $24,000
Q2 2018

Jul 09, 2018

BUY
$2.75 - $3.85 $38,500 - $53,900
14,000 New
14,000 $38,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Corrado Advisors, LLC Portfolio

Follow Corrado Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corrado Advisors, LLC with notifications on news.